Leukemia gene mutations linked to survival odds
Advances in genetic profiling are paving the way for more precise, and effective, treatment of the aggressive bone marrow cancer known as acute mylogenous leukemia, or AML, according to new research. Two studies show genetic testing can guide doctors in how best to use current therapies as well as identify new drug targets.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063